SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 203 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $329,280 | -90.0% | 16,000 | -77.3% | 0.00% | -100.0% |
| Q2 2023 | $3,308,374 | +1175.6% | 70,361 | +934.7% | 0.01% | +140.0% |
| Q4 2022 | $259,352 | -27.1% | 6,800 | -25.3% | 0.01% | -28.6% |
| Q3 2022 | $356,000 | -66.8% | 9,100 | -72.6% | 0.01% | -76.7% |
| Q2 2022 | $1,072,000 | -66.7% | 33,199 | -56.1% | 0.03% | -70.0% |
| Q4 2021 | $3,219,000 | +507.4% | 75,679 | +310.3% | 0.10% | -14.5% |
| Q1 2020 | $530,000 | -94.4% | 18,445 | -72.8% | 0.12% | -79.4% |
| Q3 2019 | $9,512,000 | +3358.9% | 67,799 | +4419.9% | 0.57% | +1790.0% |
| Q2 2019 | $275,000 | – | 1,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |